Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to divest its international enterprises in the months to come. | Stryker is selling off its spine implant business—starting with a plan to spin off its U.

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its outlook for 2025.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter. Stryker’s spinal implants business brought in $707 million in sales in 2024, and Lobo clarified that the “entire $700 million is expected to be divested to [VB Spine].”

Medical technology company Stryker plans to sell its U.S. spinal implants business to investment firm Viscogliosi Brothers for an undisclosed amount, the company announced Tuesday. The deal is expected to close in the first half of this year, creating an independent company called VB Spine.

Stryker Corporation SYK recently announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space,